177 related articles for article (PubMed ID: 7799997)
1. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice.
Guérette B; Asselin I; Vilquin JT; Roy R; Tremblay JP
Muscle Nerve; 1995 Jan; 18(1):39-51. PubMed ID: 7799997
[TBL] [Abstract][Full Text] [Related]
2. Increased granzyme B mRNA after alloincompatible myoblast transplantation.
Guérette B; Roy R; Tremblay M; Asselin I; Kinoshita I; Puymirat J; Tremblay JP
Transplantation; 1995 Nov; 60(9):1011-6. PubMed ID: 7491674
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mice.
Guérette B; Asselin I; Vilquin JT; Roy R; Tremblay JP
Transplant Proc; 1994 Dec; 26(6):3461-2. PubMed ID: 7998223
[No Abstract] [Full Text] [Related]
4. A role for natural killer cells in the rapid death of cultured donor myoblasts after transplantation.
Hodgetts SI; Spencer MJ; Grounds MD
Transplantation; 2003 Mar; 75(6):863-71. PubMed ID: 12660516
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice.
Kinoshita I; Vilquin JT; Tremblay JP
Muscle Nerve; 1995 Aug; 18(8):834-41. PubMed ID: 7630343
[TBL] [Abstract][Full Text] [Related]
6. Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection.
Huard J; Roy R; Guérette B; Verreault S; Tremblay G; Tremblay JP
Muscle Nerve; 1994 Feb; 17(2):224-34. PubMed ID: 8114793
[TBL] [Abstract][Full Text] [Related]
7. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice.
Huard J; Verreault S; Roy R; Tremblay M; Tremblay JP
J Clin Invest; 1994 Feb; 93(2):586-99. PubMed ID: 8113396
[TBL] [Abstract][Full Text] [Related]
8. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression.
Kinoshita I; Vilquin JT; Guérette B; Asselin I; Roy R; Tremblay JP
Muscle Nerve; 1994 Dec; 17(12):1407-15. PubMed ID: 7526208
[TBL] [Abstract][Full Text] [Related]
9. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
Kinoshita I; Huard J; Tremblay JP
Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
[TBL] [Abstract][Full Text] [Related]
10. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y
Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108
[TBL] [Abstract][Full Text] [Related]
11. Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice.
Asselin I; Tremblay M; Vilquin JT; Guérette B; Roy R; Tremblay JP
Muscle Nerve; 1995 Sep; 18(9):980-6. PubMed ID: 7643878
[TBL] [Abstract][Full Text] [Related]
12. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.
Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG
Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980
[TBL] [Abstract][Full Text] [Related]
13. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene.
Moisset PA; Skuk D; Asselin I; Goulet M; Roy B; Karpati G; Tremblay JP
Biochem Biophys Res Commun; 1998 Jun; 247(1):94-9. PubMed ID: 9636661
[TBL] [Abstract][Full Text] [Related]
14. Irradiation of dystrophic host tissue prior to myoblast transfer therapy enhances initial (but not long-term) survival of donor myoblasts.
Hodgetts SI; Grounds MD
J Cell Sci; 2003 Oct; 116(Pt 20):4131-46. PubMed ID: 12972504
[TBL] [Abstract][Full Text] [Related]
15. Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts.
Moisset PA; Gagnon Y; Karpati G; Tremblay JP
Gene Ther; 1998 Oct; 5(10):1340-6. PubMed ID: 9930339
[TBL] [Abstract][Full Text] [Related]
16. Normal myoblast implantation in MDX mice prevents muscle damage by exercise.
Brussee V; Merly F; Tardif F; Tremblay JP
Biochem Biophys Res Commun; 1998 Sep; 250(2):321-7. PubMed ID: 9753628
[TBL] [Abstract][Full Text] [Related]
17. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
[TBL] [Abstract][Full Text] [Related]
18. [Muscle regeneration in mdx mouse, and a trial of normal myoblast transfer into regenerating dystrophic muscle].
Takemitsu M; Arahata K; Nonaka I
Rinsho Shinkeigaku; 1990 Oct; 30(10):1066-72. PubMed ID: 2279357
[TBL] [Abstract][Full Text] [Related]
19. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
[TBL] [Abstract][Full Text] [Related]
20. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy.
Qu Z; Huard J
Gene Ther; 2000 Mar; 7(5):428-37. PubMed ID: 10694825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
